Vroom (VRM) Announces Launch of 9M Share Follow-On Offering

Vroom, Inc. (Nasdaq: VRM) (“Vroom”), a leading e-commerce platform for buying and selling used vehicles, today announced that it has commenced an underwritten public offering of its common stock. Vroom is offering 9,000,000 shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the “SEC”). Vroom expects to grant the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of its common stock at the public offering price, less the underwriting discount.

Goldman Sachs & Co. LLC, BofA Securities, Allen & Company LLC and Wells Fargo Securities are serving as joint lead book-running managers and as representatives of the underwriters for the proposed offering. Stifel, William Blair, Baird, JMP Securities, Piper Sandler​ and Wedbush Securities are serving as co-managers for the offering.

The offering will be made only by means of a prospectus. A copy of the preliminary prospectus relating to the proposed offering may be obtained from any of the following sources:

• Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, via telephone: 1-866-471-2526, or via email: [email protected];
• BofA Securities, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention: Prospectus Department or by email at [email protected];
• Allen & Company LLC, Attention: Prospectus Department, 711 Fifth Avenue, New York, NY 10022, via telephone: (212) 339-2696, or via email: [email protected]; or
• Wells Fargo Securities, Attention: Equity Syndicate Department, 500 West 33rd Street, New York, New York, 10001, at (800) 326-5897 or email a request to [email protected].

A registration statement on Form S-1 relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

You May Also Be Interested In

• Moderna prices $2.6B convertible notes offering due 2032
• JATT III Acquisition Corp closes $69M IPO on Nasdaq
• N-able expands share repurchase program by $50 million